Frequently Asked Questions

---

Rex Instruments™ is a startup company innovating the next breakthrough medical devices.

We are currently optimizing the prototype of our first product. This product is the Bronchoscopus Rex™, a single-use bronchoscope that comes in 3 sizes (Slim, Regular, and Large). The Bronchoscopus Rex is expected to be the first of many Endoscopus Rex™ single-use endoscopes utilizing our patent pending features and innovations.

Bronchoscopy is a minimally invasive procedure that can be used for diagnostic or therapeutic purposes. 

Bronchosocopy can be performed to inspect the air passages of the lungs and upper airways; to collect fluid or tissue samples for evaluation; to therapeutically remove foreign bodies, tumors, thick secretions, and blood clots; to place airway stents; to aid in intubation; and ablation of abnormal tissue. 

Single-use flexible bronchoscopes feature a camera and LEDs at their tip to provide visual feedback for the clinicians. Most feature a working channel to allow for suction and passage of instruments. In current slim scopes, the channel is too small to allow for passage of instruments so it is mainly used for airway inspection.

The Bronchoscopus Rex has numerous patent pending features that contribute to its superior performance over currently marketed bronchoscopes. 

Check out the suction bench study results on the Bronchoscopus Rex™ Page to see just how significant the improvements are in suction capabilities.

Rex Instruments is still very early in the business and product development phase. We began developing the Bronchoscopus Rex in 2022. We currently have 6 functional prototypes (2 versions, each version coming in 3 sizes). We have recently filed a provisional patent application after conducting a thorough patent search. We are now entering a promotional phase seeking SEED funding, while further refining the design and implementing more features that redefine what is possible in single-use bronchoscopes. If you have suggestions or want to help, please contact us!

As of 2022, the global bronchoscope market was valued at $2.71 billion[1]. As of 2022, the global single-use bronchoscope market was valued at $330.4 million with a CAGR of 23.6%[2]. The United States accounts for 30.2% of the single-use bronchoscope market [2]. The global single-use bronchoscope market is expected to reach $3.26 billion by 2033 [2]. 

The bronchoscope market is growing rapidly due to a number of factors. Such factors include the transition from surgical to minimally invasive procedures; greater incidence in diseases affecting the respiratory system such as COPD, lung cancer, and respiratory viruses; and a growing elderly population. 

Single-use, disposable bronchoscopes are gaining more widespread adoption due to reduced costs and preparation per procedure as well as a reduced risk of infection. The average cost per use of a reusable scope is approximately $406, while the average cost per use of a single-use scope is approximately $249, resulting in a cost savings of $157 per procedure [3].

The key players in this market include:

Ambu

Olympus

Verathon

The Surgical Company

PENTAX

Boston Scientific

It remains a highly competitive, fragmented market.